Fred Alger Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $219K | Sell |
283
-135
| -32% | -$103K | ﹤0.01% | 421 |
|
|
2025
Q4 | $323K | Sell |
418
-95
| -19% | -$64.5K | ﹤0.01% | 419 |
|
|
2025
Q3 | $288K | Buy |
513
+32
| +7% | +$18.1K | ﹤0.01% | 425 |
|
|
2025
Q2 | $253K | Buy |
481
+104
| +28% | +$58K | ﹤0.01% | 411 |
|
|
2025
Q1 | $239K | Buy |
+377
| New | +$259K | ﹤0.01% | 407 |
|
|
2024
Q4 | – | Sell |
-8,821
| Closed | -$9.27M | – | 460 |
|
|
2024
Q3 | $9.27M | Sell |
8,821
-2,302
| -21% | -$2.56M | 0.04% | 188 |
|
|
2024
Q2 | $11.7M | Sell |
11,123
-36,878
| -77% | -$35.7M | 0.06% | 173 |
|
|
2024
Q1 | $46.2M | Sell |
48,001
-2,596
| -5% | -$2.47M | 0.23% | 86 |
|
|
2023
Q4 | $44.4M | Sell |
50,597
-12,323
| -20% | -$10.1M | 0.24% | 87 |
|
|
2023
Q3 | $51.8M | Buy |
62,920
+62,836
| +74,805% | +$49.4M | 0.3% | 87 |
|
|
2023
Q2 | $60.4K | Sell |
84
-62,665
| -100% | -$48.3M | ﹤0.01% | 456 |
|
|
2023
Q1 | $51.6M | Buy |
62,749
+33,359
| +114% | +$25.2M | 0.28% | 111 |
|
|
2022
Q4 | $21.2M | Buy |
29,390
+16,831
| +134% | +$12.4M | 0.11% | 164 |
|
|
2022
Q3 | $8.65M | Buy |
+12,559
| New | +$7.9M | 0.04% | 216 |
|
|
2020
Q4 | – | Sell |
-10,557
| Closed | -$5.91M | – | 497 |
|
|
2020
Q3 | $5.91M | Sell |
10,557
-1,500
| -12% | -$910K | 0.02% | 233 |
|
|
2020
Q2 | $7.52M | Buy |
12,057
+1,242
| +11% | +$705K | 0.02% | 201 |
|
|
2020
Q1 | $5.28M | Buy |
+10,815
| New | +$4.46M | 0.02% | 211 |
|
|
2019
Q3 | – | Sell |
-31
| Closed | -$10K | – | 533 |
|
|
2019
Q2 | $10K | Sell |
31
-80,712
| -100% | -$26.9M | ﹤0.01% | 492 |
|
|
2019
Q1 | $33.2M | Buy |
+80,743
| New | +$33.2M | 0.13% | 142 |
|
|
2018
Q3 | – | Sell |
-1,000
| Closed | -$345K | – | 574 |
|
|
2018
Q2 | $345K | Buy |
+1,000
| New | +$313K | ﹤0.01% | 373 |
|
|
2017
Q4 | – | Sell |
-4,000
| Closed | -$1.79M | – | 585 |
|
|
2017
Q3 | $1.79M | Sell |
4,000
-2,000
| -33% | -$952K | 0.01% | 287 |
|
|
2017
Q2 | $2.95M | Buy |
+6,000
| New | +$2.63M | 0.01% | 259 |
|
|
2016
Q1 | – | Sell |
-62,962
| Closed | -$34.2M | – | 596 |
|
|
2015
Q4 | $34.2M | Sell |
62,962
-2,117
| -3% | -$1.15M | 0.17% | 98 |
|
|
2015
Q3 | $30.3M | Buy |
65,079
+54,979
| +544% | +$29.5M | 0.17% | 106 |
|
|
2015
Q2 | $5.15M | Buy |
+10,100
| New | +$4.93M | 0.02% | 301 |
|
|
2013
Q4 | – | Sell |
-59,108
| Closed | -$18.5M | – | 595 |
|
|
2013
Q3 | $18.5M | Buy |
59,108
+10,519
| +22% | +$2.77M | 0.1% | 212 |
|
|
2013
Q2 | $10.9M | Buy |
+48,589
| New | +$11.3M | 0.06% | 279 |
|
Other funds holding REGN
VCM
N
Fred Alger Management's REGN Position: Q1 2026 in Review
Fred Alger Management reduced its Regeneron Pharmaceuticals (REGN) stake by 32% in Q1 2026, selling an estimated $103K and leaving 283 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #421.
Fred Alger Management first reported a position in REGN in Q2 2013 and has held it in 27 quarters since. The position peaked at $51.8M in Q3 2023. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Fred Alger Management held 283 shares of Regeneron Pharmaceuticals worth $219K as of Q1 2026.
- Fred Alger Management sold 135 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $103K.
- Regeneron Pharmaceuticals made up ﹤0.01% of Fred Alger Management's portfolio in Q1 2026, its #421 holding.
- Fred Alger Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
- Fred Alger Management's Regeneron Pharmaceuticals position peaked at $51.8M in Q3 2023.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.